Wegovy Pill (Oral Semaglutide 25mg)
brandedFDA-approved for chronic weight management (December 2025)
Est. Cost
$149-$299/mo
The Wegovy Pill represents a milestone as the first oral GLP-1 medication approved specifically for weight management. Approved by the FDA in December 2025, this daily tablet may offer similar weight loss benefits to the injectable version without the need for weekly self-injections. For patients who are uncomfortable with needles or simply prefer the convenience of a pill, this formulation may open the door to effective GLP-1 therapy.
Dosage Format
One 25mg tablet taken daily on an empty stomach with a small sip of water
Type
Branded
Who to discuss it with
Patients who want GLP-1 therapy without injections and prefer a daily pill
Key distinction
Approved in December 2025, oral semaglutide 25mg is the first GLP-1 pill specifically approved for weight management, offering an injection-free alternative with studies suggesting approximately 16.6% weight loss.
Where to Get Wegovy Pill (Oral Semaglutide 25mg)
Provider listings related to wegovy pill (oral semaglutide 25mg). Confirm the exact formulation, current availability, and full price directly.
Hims
Available through Novo Nordisk partnership; may be the most affordable branded GLP-1 option currently available
$149-$299/mo
Ro
Branded oral semaglutide with provider consultations included; check availability as supply scales up
$199-$299/mo
How Wegovy Pill (Oral Semaglutide 25mg) Works
Oral semaglutide works through the same GLP-1 receptor agonist mechanism as the injectable form, helping to regulate appetite signals in the brain. The tablet uses a specialized absorption enhancer called SNAC that allows the peptide to be absorbed through the stomach lining. Patients take the pill daily on an empty stomach with no more than 4 ounces of plain water, then wait at least 30 minutes before eating, drinking, or taking other medications. This specific dosing routine is important for consistent absorption of the medication.
Side Effects
Common
- • Nausea
- • Diarrhea
- • Vomiting
- • Constipation
- • Abdominal pain
- • Decreased appetite
- • Heartburn or acid reflux
Serious risks and warning signs
- • Pancreatitis (rare)
- • Gallbladder problems
- • Kidney injury from dehydration
- • Thyroid C-cell tumors (observed in animal studies; relevance to humans is unclear)
- • Severe allergic reactions
Eligibility to Discuss With a Clinician
Eligibility criteria for the Wegovy Pill are similar to injectable Wegovy: adults with a BMI of 30 or greater, or 27 or greater with a weight-related comorbidity. Patients must be able to follow the specific fasting dosing instructions each morning. It is not recommended for individuals with a history of medullary thyroid carcinoma or MEN2 syndrome.
Related Medications
Provider Reviews
Explore providers in the weight loss category. This does not mean every provider offers Wegovy Pill (Oral Semaglutide 25mg); check the exact product with the provider.